Hepcidin suppression and defective iron recycling account for dysregulation of iron homeostasis in heme oxygenase-1 deficiency

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3091-3102

  Kartikasari, Apriliana E R ^a   Wagener, Frank A D T G ^b   Yachie, Akihiro ^c   Wiegerinck, Erwin T G ^a   Kemna, Erwin H J M ^a   Winkels, Dorine W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Ferroportin; Heme oxygenase 1; Hepcidin and hepaidin; Inflammation; Iron

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; CALCEIN; CATION TRANSPORT PROTEIN; FLUORESCEIN DERIVATIVE; HEME OXYGENASE 1; HEPCIDIN; IRON; METAL TRANSPORTING PROTEIN 1;

ANEMIA; ANIMAL; ARTICLE; CELL SURVIVAL; CHEMISTRY; HUMAN; INFLAMMATION; KIDNEY; LIVER; LIVER CELL CARCINOMA; METABOLISM; MONOCYTE; MOUSE; PATHOLOGY;

ANEMIA; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CARCINOMA, HEPATOCELLULAR; CATION TRANSPORT PROTEINS; CELL SURVIVAL; FLUORESCEINS; HEME OXYGENASE-1; HUMANS; INFLAMMATION; IRON; KIDNEY; LIVER; MICE; MONOCYTES;

EID: 77449083073     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00494.x     Document Type: Article

References (55)

1. Wagener FA, Volk HD, Willis D. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev. 2003, 55:551-71.
2. Bauer I, Wanner GA, Rensing H. Expression pattern of heme oxygenase isoenzymes 1 and 2 in normal and stress-exposed rat liver. Hepatology. 1998, 27:829-38.
3. Ganz T, Nemeth E. Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta. 2006, 1763:690-9.
4. Nemeth E, Tuttle MS, Powelson J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004, 306:2090-3.
5. Donovan A, Lima CA, Pinkus JL. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005, 1:191-200.
6. Swinkels DW, Janssen MC, Bergmans J. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem. 2006, 52:950-68.
7. Nemeth E, Rivera S, Gabayan V. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004, 113:1271-6.
8. Kemna EH, Pickkers P, Nemeth E. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood. 2005, 106:1864-6.
9. Roy CN, Mak HH, Akpan I. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood. 2007, 109:4038-44.
10. Pak M, Lopez MA, Gabayan V. Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006, 108:3730-5.
11. Yachie A, Niida Y, Wada T. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999, 103:129-35.
12. Kawashima A, Oda Y, Yachie A. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol. 2002, 33:125-30.
13. Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA. 1997, 94:10919-24.
14. Ferris CD, Jaffrey SR, Sawa A. Heme oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol. 1999, 1:152-7.
15. Baranano DE, Wolosker H, Bae BI. A mammalian iron ATPase induced by iron. J Biol Chem. 2000, 275:15166-73.
16. Wagener FA, Eggert A, Boerman OC. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood. 2001, 98:1802-11.
17. de Kok JB, Ruers TJ, van Muijen GN. Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. Clin Chem. 2000, 46:313-8.
18. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
19. Epsztejn S, Kakhlon O, Glickstein H. Fluorescence analysis of the labile iron pool of mammalian cells. Anal Biochem. 1997, 248:31-40.
20. Kartikasari AE, Georgiou NA, Visseren FL. Endothelial activation and induction of monocyte adhesion by nontransferrin-bound iron present in human sera. FASEB J. 2006, 20:353-5.
21. Masereeuw R, Notenboom S, Smeets PH. Impaired renal secretion of substrates for the multidrug resistance protein 2 in mutant transport-deficient (TR-) rats. J Am Soc Nephrol. 2003, 14:2741-9.
22. Kemna EH, Tjalsma H, Podust VN. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem. 2007, 53:620-8.
23. Smith A, Alam J, Escriba PV. Regulation of heme oxygenase and metallothionein gene expression by the heme analogs, cobalt-, and tin-protoporphyrin. J Biol Chem. 1993, 268:7365-71.
24. Sardana MK, Kappas A. Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci USA. 1987, 84:2464-8.
25. Shan Y, Lambrecht RW, Donohue SE. Role of Bach1 and Nrf2 in up-regulation of the heme oxygenase-1 gene by cobalt protoporphyrin. FASEB J. 2006, 20:2651-3.
26. Kappas A, Drummond GS, Henschke C. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics. 1995, 95:468-74.
27. di Patti MC, Persichini T, Mazzone V. Interleukin-1beta up-regulates iron efflux in rat C6 glioma cells through modulation of ceruloplasmin and ferroportin-1 synthesis. Neurosci Lett. 2004, 363:182-6.
28. Verga Falzacappa MV, Vujic SM, Kessler R. STAT-3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2006, 109:353-8.
29. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006, 108:3204-9.
30. Tron K, Samoylenko A, Musikowski G. Regulation of rat heme oxygenase-1 expression by interleukin-6 via the Jak/STAT pathway in hepatocytes. J Hepatol. 2006, 45:72-80.
31. Gehrke SG, Kulaksiz H, Herrmann T. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood. 2003, 102:371-6.
32. Nemeth E, Valore EV, Territo M. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003, 101:2461-3.
33. Vokurka M, Krijt J, Sulc K. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res. 2006, 55:667-74.
34. Kattamis A, Papassotiriou I, Palaiologou D. The effects of erythropoietic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica. 2006, 91:809-12.
35. Tanno T, Bhanu NV, Oneal PA. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007, 13:1096-101.
36. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta. 2003, 329:9-22.
37. Willis D, Moore AR, Frederick R. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med. 1996, 2:87-90.
38. Koizumi S. Human heme oxygenase-1 deficiency: a lesson on serendipity in the discovery of the novel disease. Pediatr Int. 2007, 49:125-32.
39. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA. 1997, 94:10925-30.
40. Wiesel P, Patel AP, DiFonzo N. Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation. 2000, 102:3015-22.
41. Nath KA, Haggard JJ, Croatt AJ. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol. 2000, 156:1527-35.
42. Balla J, Vercellotti GM, Jeney V. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res. 2005, 49:1030-43.
43. Maruhashi K, Kasahara Y, Ohta K. Paradoxical enhancement of oxidative cell injury by overexpression of heme oxygenase-1 in an anchorage-dependent cell ECV304. J Cell Biochem. 2004, 93:552-62.
44. De FL, Daraio F, Filippini A. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia. Haematologica. 2006, 91:1336-42.
45. Frazer DM, Inglis HR, Wilkins SJ. Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut. 2004, 53:1509-15.
46. Peyssonnaux C, Zinkernagel AS, Schuepbach RA. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest. 2007, 117:1926-32.
47. Silvestri L, Pagani A, Camaschella C. Furin mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood. 2007, 111:924-31.
48. McKie AT, Marciani P, Rolfs A. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000, 5:299-309.
49. Lin L, Valore EV, Nemeth E. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP/. Blood. 2007, 110:2182-9.
50. Bissell DM, Guzelian PS. Degradation of endogenous hepatic heme by pathways not yielding carbon monoxide. Studies in normal rat liver and in primary hepatocyte culture. J Clin Invest. 1980, 65:1135-40.
51. Ponka P. Cell biology of heme. Am J Med Sci. 1999, 318:241-56.
52. Papanikolaou G, Samuels ME, Ludwig EH. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004, 36:77-82.
53. van Dijk BA, Kemna EH, Tjalsma H. Effect of the new HJV-L165X mutation on penetrance of HFE. Blood. 2007, 109:5525-6.
54. Papanikolaou G, Tzilianos M, Christakis JI. Hepcidin in iron overload disorders. Blood. 2005, 105:4103-5.
55. Scharstuhl A, Mutsaers HAM, Pennings SWC. Curcumin-induced fibroblast apoptosis and in vitro wound contraction are regulated by antioxidants and heme oxygenase: implications for scar formation. J Cell Mol Med. 2009, 712-25.